Results 331 to 340 of about 315,322 (362)
Some of the next articles are maybe not open access.
HLA epitopes and graft survival.
Clinical transplants, 19921. The fraction of patients and graft survival was provided for amino acid residues, heptapeptides, and conformational epitopes with HLA specificities of up to 7 antigens mismatched. 2. Mismatching large numbers of serologically defined residues was detrimental to graft survival, whereas nonserologically defined residues did not have an effect. 3.
S, Takemoto, P I, Terasaki
openaire +1 more source
Fifteen-year kidney graft survival.
Clinical transplants, 19911. Among patients transplanted in 93 selected centers with good follow-up data, the 10-year graft survival of first cadaver-donor transplants was 18%, parental donor grafts 39%, and HLA-identical sibling donor grafts 66%. The respective half-lives were 6.8, 10.8, and 24.5 years.
Y W, Cho, P I, Terasaki, B, Graver
openaire +1 more source
Cancer treatment and survivorship statistics, 2022
Ca-A Cancer Journal for Clinicians, 2022Kimberly D Miller +2 more
exaly